Office of Research and Development Publications

Aspirin pre-treatment modulates ozone-induced fetal growth restriction and alterations in uterine blood flow in rats

Citation:

Miller, C., U. Kodavanti, E. Stewart, M. Schladweiler, J. Richards, A. Ledbetter, L. Jarrell, S. Snow, A. Henriquez, A. Farraj, AND J. Dye. Aspirin pre-treatment modulates ozone-induced fetal growth restriction and alterations in uterine blood flow in rats. REPRODUCTIVE TOXICOLOGY. Elsevier Science Ltd, New York, NY, 83:63-72, (2019). https://doi.org/10.1016/j.reprotox.2018.12.002

Impact/Purpose:

Therefore, in the present study, we hypothesized that prophylactic, aspirin administration (0.6 mg/day; equivalent to 2 mg/kg in a 250 mg rodent) in Long-Evans rats could lessen the degree of ozone-mediated fetal growth restriction.

Description:

Prenatal exposure to ozone has been linked to low birth weight in people and fetal growth restriction in rats. Clinical recommendations suggest use of low dose aspirin to lower risk of preeclampsia and intrauterine growth restriction in high-risk pregnancies, yet its utility in mitigating the postnatal effects of gestational ozone exposure is unknown. The present study investigated the possibility of low dose aspirin to mitigate the effects of ozone exposure during pregnancy. Exposure to ozone impaired uterine arterial flow and induced growth restriction in fetuses of both sexes. Aspirin treatment induced marginal improvements in ozone-induced uterine blood flow impairment. However, this resulted in a protection of fetal weight in dams given aspirin only in early pregnancy. Aspirin administration for the entirety of gestation increased placental weight and reduced antioxidant status, suggesting that prolonged exposure to low dose aspirin may induce placental inefficiency in our model of growth restriction.

Record Details:

Record Type:DOCUMENT( JOURNAL/ PEER REVIEWED JOURNAL)
Product Published Date:01/01/2019
Record Last Revised:05/01/2019
OMB Category:Other
Record ID: 344939